Melanoma Coverage from Every Angle
Advertisement
Advertisement

Georgina V. Long, MD, PhD, on Metastatic Melanoma: Results of the Anti–PD-1 Brain Collaboration

Posted: Thursday, March 22, 2018

Georgina V. Long, MD, PhD, of the Melanoma Institute of Australia, University of Sydney, discusses phase II study results on nivolumab or nivolumab combined with ipilimumab in patients with melanoma brain metastases.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.